Results for „Arzneimittel"
33 results
News
- Bonus system for prescription-only medicinal products not permitted
- Discounts on price-bound pharmaceuticals impermissible
- Contract Manufacturing Agreements for Pharmaceuticals and Medical Devices
- Contract Manufacturing of Pharmaceutical Products and Medical Devices
- Distance selling of pharmaceutical veterinary medicinal products via the internet?
- Advertising for pharmaceutical products on the Internet permitted?
- Is pharmaceutical authorisation required for antibacterial mouthwash?
- Permissibility of discount and bonus systems operated by EU mail-order pharmacies
- Pharmacy collection model for prescription medicines
- E-Cigarette: A Medicinal Product or Medical Device?
- Prescription-only medicines without a prescription?
- Product imitation by similar pharmaceutical packaging
- Pharmacist advertising in medical practice permitted?
- Advertising for homeopathic medicinal products misleading
- Advertising with the ® symbol (R in a circle)
- Mandatory information for medicinal products must be correctly placed!
- Hanseatic Higher Regional Court (OLG) sets the standard for pharmaceutical advertising
- Caution regarding voluntary statements on medicinal product packaging, package leaflets and summary of product characteristics
- Drug or cosmetic product? On the judgment of the Administrative Court of Cologne (Verwaltungsgericht Köln) of 13.08.2024 (Az. 7 K 2494/22)
- News on pharmaceutical advertising: Key findings from the Court of Justice of the European Union (EuGH) ruling (C-517/23) – in the matter of DocMorris RX bonuses
- Pharmacological Effect – Medicinal Product or Medical Device?
- Third-party protection in parallel importation of medicinal products – referral decision of the BVerwG to the EuGH of 20.03.2025
- Federal Court of Justice (BGH) decision: Former pharmaceutical price binding cannot be applied to EU mail-order pharmacies – mail-order pharmacies are permitted to grant bonuses
- Presentation medicinal product: Administrative Court of Schwerin classifies hoof care product as medicinal product and confirms marketing ban
- Medicinal product or foodstuff? – CJEU clarifies the priority rule for borderline products
- The Federal Court of Justice (BGH) draws the red line between beauty claim and health claim – 'Beautiful skin ≠ free pass'
- Voucher advertising for pharmacies: limits of medicinal product advertising and liability under § 945 ZPO
- Drug property of Femannose – manufacturers of borderline products must be careful
- €25 Voucher for e-Prescriptions Prohibited – Higher Regional Court of Karlsruhe Tightens the Limits of Discount Advertising under the Medicines Advertising Act
- GCP violations: pharmaceutical law studies prohibited even in case of abstract risk
- Pharmaceutical trademarks in focus: EUIPO rejects 'BIALVIZ' due to likelihood of confusion with 'BYOOVIZ'
- Revived Data Exclusivity: EU Court Confirms Withdrawal of Generic Authorisation
- Federal Court of Justice (BGH): Advertising for Medical Cannabis – Intermediary Platforms in Focus of HWG